Abstract:Background Tumor-associated macrophages (TAMs) play key roles in the development of many malignant solid tumors including breast cancer. They are educated in the tumor microenvironment (TME) to promote tumor growth, metastasis, and therapy resistance. However, the phenotype of TAMs is elusive and how to regulate them for therapeutic purpose remains unclear; therefore, TAM-targeting therapies have not yet achieved clinical success. The purposes of this study were to examine the role of transcription factor EB (TFEB) in regulating TAM gene expression and function and to determine if TFEB activation can halt breast tumor development. Methods Microarrays were used to analyze the gene expression profile of macrophages (MΦs) in the context of breast cancer and to examine the impact of TFEB overexpression. Cell culture studies were performed to define the mechanisms by which TFEB affects MΦ gene expression and function. Mouse studies were carried out to investigate the impact of MΦ TFEB deficiency or activation on breast tumor growth. Human cancer genome data were analyzed to reveal the prognostic value of TFEB and its regulated genes. Results TAM-mimic MΦs display a unique gene expression profile, including significant reduction in TFEB expression. TFEB overexpression favorably modulates TAM gene expression through multiple signaling pathways. Specifically, TFEB upregulates suppressor of cytokine signaling 3 (SOCS3) and peroxisome proliferator-activated receptor γ (PPARγ) expression and autophagy/lysosome activities, inhibits NLRP3 (NLR Family Pyrin Domain Containing 3) inflammasome and hypoxia-inducible factor (HIF)-1α mediated hypoxia response, and thereby suppresses an array of effector molecules in TAMs including arginase 1, interleukin (IL)-10, IL-1β, IL-6 and prostaglandin E2. MΦ-specific TFEB deficiency promotes, while activation of TFEB using the natural disaccharide trehalose halts, breast tumor development by modulating TAMs. Analysis of human patient genome database reveals that expression levels of TFEB, SOCS3 and PPARγ are positive prognostic markers, while HIF-1α is a negative prognostic marker of breast cancer. Conclusions Our study identifies TFEB as a master regulator of TAMs in breast cancer. TFEB controls TAM gene expression and function through multiple autophagy/lysosome-dependent and independent pathways. Therefore, pharmacological activation of TFEB would be a promising therapeutic approach to improve the efficacy of existing treatment including immune therapies for breast cancer by favorably modulating TAM function and the TME.

TFEB-dependent autophagy is involved in scavenger receptor OLR1/LOX-1-mediated tumor progression

Autophagy Facilitates TLR4- and TLR3-triggered Migration and Invasion of Lung Cancer Cells Through the Promotion of TRAF6 Ubiquitination

TFEB regulates tumor-associated macrophages in breast cancer through autophagy-dependent and independent pathways

A new glance at autophagolysosomal-dependent or -independent function of transcriptional factor EB in human cancer

TFEB-driven Autophagy Potentiates TGF-β Induced Migration in Pancreatic Cancer Cells.

The "Self-eating" of cancer-associated fibroblast: A potential target for cancer

The "Self-eating" of cancer-associated fibroblast: A potential target for cancer.

TFEB: a double-edged sword for tumor metastasis

Targeting lectin-like oxidized low-density lipoprotein receptor-1 triggers autophagic program in esophageal cancer

A small-molecule drug inhibits autophagy gene expression through the central regulator TFEB

Transcription factor EB is involved in autophagy-mediated chemoresistance to doxorubicin in human cancer cells

Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance

The mechanism by which SIRT1 regulates autophagy and EMT in drug-resistant oesophageal cancer cells

Inhibiting autophagy before it starts

Autophagy-Dependent Ferroptosis in Cancer

Lactylation stabilizes TFEB to elevate autophagy and lysosomal activity

TFEB is a master regulator of tumor-associated macrophages in breast cancer

Autophagy is Involved in TGF-β1-induced Protective Mechanisms and Formation of Cancer-Associated Fibroblasts Phenotype in Tumor Microenvironment.

Oblongifolin C Suppresses Lysosomal Function Independently of TFEB Nuclear Translocation

Abstract 1029: Rab1A and Rab1B Promote Esophageal Squamous Cell Carcinoma Through Activating Mtorc1 Signaling and Inhibiting Autophagy

Autophagy supports generation of cells with high CD44 expression via modulation of oxidative stress and Parkin-mediated mitochondrial clearance